Detalles de la búsqueda
1.
Microcystic elongated and fragmented (MELF) pattern of invasion: Molecular features and prognostic significance in the PORTEC-1 and -2 trials.
Gynecol Oncol
; 166(3): 530-537, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35840357
2.
Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy.
Br J Cancer
; 119(9): 1067-1074, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30356126
3.
Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial.
Gynecol Oncol
; 151(1): 69-75, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30078506
4.
Treatment preferences and involvement in treatment decision making of patients with endometrial cancer and clinicians.
Br J Cancer
; 111(4): 674-9, 2014 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-24921911
5.
Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
Lancet
; 375(9717): 816-23, 2010 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-20206777
6.
Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer.
Radiother Oncol
; 155: 160-166, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33159971
7.
Keratinocyte growth factor ameliorates acute graft-versus-host disease in a novel nonmyeloablative haploidentical transplantation model.
Bone Marrow Transplant
; 36(10): 907-15, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16151417
8.
Consecutive magnetic resonance imaging during brachytherapy for cervical carcinoma: predictive value of volume measurements with respect to persistent disease and prognosis.
Radiat Oncol
; 10: 252, 2015 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26642877
9.
Age-specific differences in treatment and survival of patients with cervical cancer in the southeast of The Netherlands, 1986-1996.
Eur J Cancer
; 38(15): 2041-7, 2002 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12376210
10.
Citrulline: a potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapy.
Bone Marrow Transplant
; 34(3): 193-6, 2004 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-15170165
11.
Point-counterpoint: what is the optimal trial design to test hyperthermia for carcinoma of the cervix? Point: addition of hyperthermia or cisplatin to radiotherapy for patients with cervical cancer; two promising combinations--no definite conclusions.
Int J Hyperthermia
; 18(1): 19-24, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-11824390
Resultados
1 -
11
de 11
1
Próxima >
>>